147 related articles for article (PubMed ID: 30240745)
1. Mutant and Wild-Type Tumor Suppressor p53 Induces p300 Autoacetylation.
Kaypee S; Sahadevan SA; Patil S; Ghosh P; Roy NS; Roy S; Kundu TK
iScience; 2018 Jun; 4():260-272. PubMed ID: 30240745
[TBL] [Abstract][Full Text] [Related]
2. Oligomers of human histone chaperone NPM1 alter p300/KAT3B folding to induce autoacetylation.
Kaypee S; Sahadevan SA; Sudarshan D; Halder Sinha S; Patil S; Senapati P; Kodaganur GS; Mohiyuddin A; Dasgupta D; Kundu TK
Biochim Biophys Acta Gen Subj; 2018 Aug; 1862(8):1729-1741. PubMed ID: 29746960
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation.
Stiehl DP; Fath DM; Liang D; Jiang Y; Sang N
Cancer Res; 2007 Mar; 67(5):2256-2264. PubMed ID: 17332356
[TBL] [Abstract][Full Text] [Related]
4. Autoacetylation induced specific structural changes in histone acetyltransferase domain of p300: probed by surface enhanced Raman spectroscopy.
Arif M; Kumar GV; Narayana C; Kundu TK
J Phys Chem B; 2007 Oct; 111(41):11877-9. PubMed ID: 17894486
[TBL] [Abstract][Full Text] [Related]
5. Histone modifications affect differential regulation of TGFβ- induced NADPH oxidase 4 (NOX4) by wild-type and mutant p53.
Boudreau HE; Ma WF; Korzeniowska A; Park JJ; Bhagwat MA; Leto TL
Oncotarget; 2017 Jul; 8(27):44379-44397. PubMed ID: 28574838
[TBL] [Abstract][Full Text] [Related]
6. ING5 differentially regulates protein lysine acetylation and promotes p300 autoacetylation.
Zhang T; Meng J; Liu X; Zhang X; Peng X; Cheng Z; Zhang F
Oncotarget; 2018 Jan; 9(2):1617-1629. PubMed ID: 29416718
[TBL] [Abstract][Full Text] [Related]
7. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity.
Sang N; Avantaggiati ML; Giordano A
J Cell Biochem; 1997 Sep; 66(3):277-85. PubMed ID: 9257185
[TBL] [Abstract][Full Text] [Related]
8. The SIRT2 deacetylase regulates autoacetylation of p300.
Black JC; Mosley A; Kitada T; Washburn M; Carey M
Mol Cell; 2008 Nov; 32(3):449-55. PubMed ID: 18995842
[TBL] [Abstract][Full Text] [Related]
9. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.
Ito A; Lai CH; Zhao X; Saito S; Hamilton MH; Appella E; Yao TP
EMBO J; 2001 Mar; 20(6):1331-40. PubMed ID: 11250899
[TBL] [Abstract][Full Text] [Related]
10. Multiple roles for acetylation in the interaction of p300 HAT with ATF-2.
Karanam B; Wang L; Wang D; Liu X; Marmorstein R; Cotter R; Cole PA
Biochemistry; 2007 Jul; 46(28):8207-16. PubMed ID: 17590016
[TBL] [Abstract][Full Text] [Related]
11. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein.
Scolnick DM; Chehab NH; Stavridi ES; Lien MC; Caruso L; Moran E; Berger SL; Halazonetis TD
Cancer Res; 1997 Sep; 57(17):3693-6. PubMed ID: 9288775
[TBL] [Abstract][Full Text] [Related]
12. ZBP-89 mediates butyrate regulation of gene expression.
Merchant JL; Bai L; Okada M
J Nutr; 2003 Jul; 133(7 Suppl):2456S-2460S. PubMed ID: 12840224
[TBL] [Abstract][Full Text] [Related]
13. Tumor Suppressor p53-Mediated Structural Reorganization of the Transcriptional Coactivator p300.
Ghosh R; Kaypee S; Shasmal M; Kundu TK; Roy S; Sengupta J
Biochemistry; 2019 Aug; 58(32):3434-3443. PubMed ID: 31314496
[TBL] [Abstract][Full Text] [Related]
14. The adenovirus E1A oncoprotein N-terminal transcriptional repression domain enhances p300 autoacetylation and inhibits histone H3 Lys18 acetylation.
Zhao LJ; Loewenstein PM; Green M
Genes Cancer; 2015 Jan; 6(1-2):30-7. PubMed ID: 25821559
[TBL] [Abstract][Full Text] [Related]
15. P300 Participates in Ionizing Radiation-Mediated Activation of Cathepsin L by Mutant p53.
Xiong YJ; Zhu Y; Liu YL; Zhao YF; Shen X; Zuo WQ; Lin F; Liang ZQ
J Pharmacol Exp Ther; 2021 Sep; 378(3):276-286. PubMed ID: 34253647
[TBL] [Abstract][Full Text] [Related]
16. Acetylation of Sirt2 by p300 attenuates its deacetylase activity.
Han Y; Jin YH; Kim YJ; Kang BY; Choi HJ; Kim DW; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2008 Oct; 375(4):576-80. PubMed ID: 18722353
[TBL] [Abstract][Full Text] [Related]
17. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
Thomas MC; Chiang CM
Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
[TBL] [Abstract][Full Text] [Related]
18. HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53.
Sasaki T; Gan EC; Wakeham A; Kornbluth S; Mak TW; Okada H
Genes Dev; 2007 Apr; 21(7):848-61. PubMed ID: 17403783
[TBL] [Abstract][Full Text] [Related]
19. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
20. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
